Within the 2 weeks of "my" 2nd  vaccine, "I" experienced bloating, extreme gas pains, diarrhea; Within the 2 weeks of "my" 2nd  vaccine, "I" experienced bloating, extreme gas pains, diarrhea; Within the 2 weeks of "my" 2nd  vaccine, "I" experienced bloating, extreme gas pains, diarrhea; Three weeks after my second vaccine "I" developed pain in the tops of "my" feet; Three weeks after "my" second vaccine "I" developed pain in the tops of "my" feet, and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows; Three weeks after "my" second vaccine "I" developed pain in the tops of "my" feet, and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows; Three weeks after "my" second vaccine "I" developed pain in the tops of "my" feet, and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows; Red blotches developed on "my" legs that were hot to touch, raised and tender; "I"  then developed severe headaches, decreased mobility; "I" then developed severe headaches, decreased mobility; The headaches can be so severe it causes "me" to shiver and chatter "my" teeth; "I" have experienced numbness on "my" bottom lip and chin.; Numbness on "my" bottom lip and chin; The redness and swelling have moved to my right hand; The redness and swelling have moved to "my" right hand; extreme stiffness in ankles, knees, and elbows; Red blotches developed on "my" legs that were hot to touch, raised and tender; Red blotches developed on "my" legs that were hot to touch, raised and tender; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 06Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The medical history included hashimoto's hypothyroidism and polycystic ovarian syndrome (PCOS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine/ liothyronine (NP THYROID) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm right on 17Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, within the 2 weeks of second vaccine, the patient experienced bloating, extreme gas pains and diarrhea. On an unknown date in 2021, three weeks after second vaccine, the patient developed pain in the tops of feet and it gradually increased to swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows. Red blotches were developed on her legs that were hot to touch, raised and tender. The patient then developed severe headaches and decreased mobility. The headaches was so severe and it caused shiver and chatter her teeth. The patient experienced numbness on the bottom lip and chin. The redness and swelling were moved to her right hand. On an unknown date in Apr2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. On an unknown date, the patient had taken an  X-ray and underwent multiple blood tests and the result were unknown. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events bloating, extreme gas pains, diarrhea, pain in the tops of feet, swollen ankles, swollen legs, extreme stiffness in ankles, knees, and elbows, red blotches legs that were hot to touch, raised and tender, severe headaches, decreased mobility, the headaches was so severe it causes shiver and chatter teeth, numbness on bottom lip and chin and redness and swelling moved to right hand were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.